South Korea Continuous Blood Glucose Monitoring Systems Market Size, Share, and COVID-19 Impact Analysis, By Component (Sensors, Transmitters, Receivers), By End-User (Hospitals, Homecare Settings, Diagnostic Centers, and Others), and South Korea Continuous Blood Glucose Monitoring Systems Market Insights, Industry Trend, Forecasts to 2035

South Korea Continuous Blood Glucose Monitoring Systems Market Insights Forecasts to 2035

• The South Korea Continuous Blood Glucose Monitoring Systems Market Size is Expected to Grow at a CAGR of around 5.3% from 2025 to 2035
• The South Korea Continuous Blood Glucose Monitoring Systems Market Size is Expected to hold a significant Share by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Continuous Blood Glucose Monitoring Systems Market Size is anticipated to grow at a CAGR of 5.3% from 2025 to 2035. The market is driven by rising diabetes prevalence, expanded reimbursement, and technological advancements in sensor accuracy and wear time, the South Korea Continuous Blood Glucose Monitoring Systems Market is experiencing rapid adoption among patients and healthcare providers.

Market Overview

The South Korea continuous blood glucose monitoring (CGM) systems market refers to the subcategory of medical devices that provides real-time glucose reading at regular intervals throughout the day and night which improves diabetes management by reducing the need for fingerstick tests. Continuous glucose monitoring systems generally consist of a small, wearable sensor, a transmitter, and a display device (often a smartphone app). Overall market growth is being driven by rising diabetes prevalence in South Korea for patient populations, increasing adoption of advanced diabetes care technologies, and efforts on behalf of the South Korean government to provide increased reimbursement and improve access. The shift towards patient-centered, data-driven care combined with CGM integration with insulin pumps and digital health platforms is assisting in achieving better treatment outcomes. Adoption is primarily constrained by high device costs, low levels of awareness in rural territories, and, in some instances, questions regarding subjectivity of data and calibration requirement and accuracy of data.

Report Coverage

This research report categorizes the market for the South Korea continuous blood glucose monitoring systems market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea continuous blood glucose monitoring systems market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea continuous blood glucose monitoring systems market.

Driving Factors

The South Korea continuous blood glucose monitoring systems market is growing due to the increased number of patients with diabetes, the growing number of physician and patient demand for real-time glucose monitoring, and increased reimbursement. Improved sensor accuracy, extended wear time, use of the device, and integration with hospital systems and digital health platforms support greater acceptance among patients and healthcare providers.

Restraining Factors

The South Korea continuous blood glucose monitoring systems market is restrained by high costs of the device, limited reimbursement coverage based on certain types of patients, lack of awareness in rural areas, and issues with sensor accuracy and calibration being necessary while limited integration with hospital systems.

Market Segmentation

The South Korea continuous blood glucose monitoring systems market share is classified into component and end-user.

• The sensors segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea continuous blood glucose monitoring systems market is segmented by component into sensors, transmitters, and receivers. Among these, the sensors segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the CGM systems support sensors as CGM’s main component for use which is directly measuring glucose levels on a continuous basis and enabling real-time monitoring to make dosing insulin decisions and effectively manage diabetes. Replacement of and sensors across many patients leads to recurring revenue for both manufacturers and distributors.

• The homecare settings segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea continuous blood glucose monitoring systems market is segmented by end-user into hospitals, homecare settings, diagnostic centers, and others. Among these, the homecare settings segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This expansion is a result of the growing patient preference for home-based management solutions for diabetes wherever possible, they see the convenience of real-time monitoring and are supporting increased knowledge of self-care activities by wearing a CGM timer and connecting to scalable digital health platforms.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea continuous blood glucose monitoring systems market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Dexcom, Inc.
• Medtronic plc
• Roche Diabetes Care, Inc.
• Novo Nordisk A/S
• Johnson & Johnson
• Sanofi S.A.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea continuous blood glucose monitoring systems market based on the below-mentioned segments:

South Korea Continuous Blood Glucose Monitoring Systems Market, By Component

• Sensors
• Transmitters
• Receivers

South Korea Continuous Blood Glucose Monitoring Systems Market, By End-User

• Hospitals
• Homecare Settings
• Diagnostic Centers
• Others